Transparency Market Research, in a report titled “Autoimmune Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” indicates that the global autoimmune disease diagnostics market is projected to expand at a 3.80% CAGR from 2015 to 2023, increasing from a value of US$12.3 bn in 2014 to US$17.1 bn by 2023.
Browse the full Autoimmune Disease Diagnostics Market: (By Test Types: Antinuclear Antibody Test, Autoantibody Test, Complete Blood Count, Comprehensive Metabolic Panel, C-Reactive Protein Test, Erythrocyte Sedimentation Rate, Urinalysis and Others; Disease: Graves’ Disease, Hashimoto’s Thyroiditis, Rheumatoid Arthritis, Multiple Sclerosis, Systemic Lupus Erythematosus, Type 1 Diabetes, and Others): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html
According to the American Autoimmune Related Diseases Association, an estimated 50 million Americans are affected by autoimmune diseases. Autoimmune diseases can affect one or several different types of body tissue and also cause abnormal organ growth. There are around 80 different types of autoimmune diseases and since many of them have similar symptoms, it is very difficult to distinguish one from the other and diagnose the disease. Some of the most common autoimmune diseases are rheumatoid arthritis, celiac disease, lupus, vitiligo, and psoriasis.
The global autoimmune disease diagnostics market is fueled by a number of factors including the increase in healthcare expenditure around the world, the higher prevalence of autoimmune diseases across the globe, and the rising awareness regarding autoimmune diseases among the people. While the development of new services, products, and devices and the sustained growth opportunities offered by emerging economies serve as major opportunities for growth for the players within the autoimmune disease diagnostics market, the shortage of skilled labor, the rising cost of equipment, and competitive pricing threaten to impede the expansion of the global market.
On the basis of test type, the autoimmune disease diagnostics market is classified into autoantibody tests, comprehensive metabolic panel, erythrocyte sedimentation rate, antinuclear antibody tests, complete blood count, C-reactive protein, urinalysis, and others. Owing to the major advantages presented by autoantibody tests such as simplicity, speed, and minimal patient discomfort, the segment of autoantibody tests dominates the global autoimmune disease diagnostics market in terms of revenue.
Based on type of disease, the autoimmune disease diagnostics market is segmented into Hashimoto’s thyroiditis, rheumatoid arthritis, type 1 diabetes, Graves’ disease, multiple sclerosis, systemic lupus erythematosus, and others. Accounting for the largest share in the global autoimmune disease diagnostics market in 2014, rheumatoid arthritis dominates the overall market in terms of revenue. This segment has been driven by the growing incidence of rheumatoid arthritis across the globe and an improvement in laboratory testing for the detection of rheumatoid arthritis.
On the basis of geography, the global autoimmune disease diagnostics market is divided into Asia Pacific, North America, Europe, and Rest of the World. In 2014, North America dominated the overall market for autoimmune disease diagnostics accounting for a 39.0% share in terms of revenue. Europe followed next and the autoimmune disease diagnostics market in both these regions has been driven by the presence of major players, the surge in patient population, and a well-structured distribution channel in place. Asia Pacific is identified to be the most rapidly expanding regional market for autoimmune disease diagnostics by 2023, fueled by the expansion of market players in the region, the rising prevalence of autoimmune diseases, an improvement in the healthcare infrastructure, and several massive untapped opportunities.
The most prominent companies competing in this space are Bio-Rad Laboratories, Quest Diagnostics, Beckman Coulter, Inc., Siemens Healthcare, F. Hoffmann-La Roche Ltd., SQI Diagnostics, Inc., bioMérieux SA, Abbott Laboratories, Inc., and Inova Diagnostics, Inc.
Global Autoimmune Disease Diagnostics Market, by Test Type
- Antinuclear Antibody Tests
- Autoantibody Tests
- Complete Blood Count (CBC)
- Comprehensive Metabolic Panel
- C - reactive protein (CRP)
- Erythrocyte Sedimentation Rate (ESR)
Global Autoimmune Disease Diagnostics Market, by Disease Type
- Graves’ Disease
- Hashimoto's Thyroiditis
- Multiple Sclerosis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (lupus)
- Type 1 diabetes
Global Autoimmune Disease Diagnostics Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453